跳至主要内容
临床试验/NL-OMON49813
NL-OMON49813招募中不适用

Prospective study on peripheral and intrahepatic immune cells derived from chronic hepatitis B patients during and after long-term treatment with direct antivirals - HBV-FNAB-002 study

Stichting Leveronderzoek0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - man or woman, age of ><=18 and <<= 70 years
  • - chronic Hepatitis B (HBsAg positive for minimum 6 months)
  • - > 3 years on treatment with direct antivirals for CHB
  • - HBV DNA undetectable or < 60 IU/mL, on NA treatment for minimal 2 years
  • - HBeAg negative, while on NA treatment for minimal 2 year
  • - ALT < 1.5 ULN (by local assay), while on NA treatment for minimal 1 year and
  • at screening
  • - no evidence of cirrhosis
  • - HBV Genotype A, B, C, D or E
  • - otherwise healthy and medically stable
  • - written informed consent

排除标准

  • - positive HIV test
  • - hepatitis A, C, D or E co-infection
  • - Subject had severe hepatitis activity (ALT >= 10xULN) while on NA(s)
  • treatment 2years before screening, or elevation ALT Level>1xULN 1 year before
  • screening and at screening
  • - decompensated cirrhosis or hepatocellular carcinoma (documented medical
  • - Subject has an underlying condition which preclude the choice of direct
  • antivirals as treatment
  • - participation in another translational research study
  • - use of any investigational drug or use of an invasive investigational medical
  • device within 90 days before screening
  • - Subject has received immuno-modulating drugs (within 18 months prior to
  • screening) for HBV
  • - any condition for which, in the opinion of the investigator, participation
  • would not be in the best interest of the subject
  • - major surgery (e.g. requiring general anaesthesia) within 12 weeks before
  • - history of drug or alcohol abuse within 1 year before screening
  • - divers lab parameters (platelets, INR, bilirubin, Hb, eGFR, AFP)
  • - anticoagulation therapy or bleeding diathesis
  • - hemoglobinopathy
  • - pregnancy or breast-feeding

研究者

发起方
Stichting Leveronderzoek

相似试验